Martin Golkowski

Martin Golkowski is an Assistant Professor of Pharmacology and Toxicology at the University of Utah School of Medicine. His work integrates chemical biology, mass spectrometry-based proteomics, and pharmacology to study kinase-mediated signaling networks driving pathological cellular plasticity in diseases such as hepatocellular carcinoma (HCC), organ fibrosis, and cancer metastasis.

• Education: B.S. and Ph.D. in Germany
• Affiliation: University of Utah (College of Pharmacy, School of Medicine, Huntsman Cancer Institute)

His research focuses on cellular plasticity mechanisms hijacked in diseases, particularly clathrin-mediated endocytosis (CME) dysregulation in HCC and tumor suppressor kinases. His lab develops innovative tools like MS-based PPI profiling platforms and PROTAC degraders to target therapeutic nodes.

Recent publications highlight his expertise in kinase interactomes, pharmacoproteomics, and chemical biology approaches. Collaborative projects span cancer biology, endocrine signaling, and drug discovery.

Students in his lab receive interdisciplinary training in proteomic techniques, chemical biology, and drug development, working across institutional boundaries.